Physician profile
James E Riordan
NPI 1821025065
$790.83
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $769 · 2022: $22.05.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $152.97 | 2021-2022 | |
| Pacira Therapeutics, INC. | $109.01 | 2021 | |
| Collegium Pharmaceutical, INC. | $100.15 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $68.20 | 2021 | |
| Abbott Laboratories | $60.10 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.83 | 2021 | |
| Novartis Pharmaceuticals Corporation | $52.91 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $45.05 | 2021 | |
| Allergan, INC. | $25.24 | 2021 | |
| Amgen INC. | $24.08 | 2021 | |
| Almatica Pharma LLC | $21.59 | 2021 | |
| Nalu Medical, INC. | $16.55 | 2021 | |
| Breg, INC | $14.95 | 2021 | |
| Lilly USA, LLC | $14.55 | 2021 | |
| Electronic Waveform Lab, INC. | $14.51 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Upsher-Smith Laboratories LLC | $14.14 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Riordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.